Advent calendar-23

So we are on our journey of drug development and if you are pharma doing studies you have the resource to seamlessly go from trial to trial, but when academics do it they have to raise funds at each stage of the game so you have to go back to funders or investors or hope that pharma take up the gauntlet.

 These usually investors drive a hard bargain
Pass this and you are on the home straight.

CoI We are attempting to develop a drug for people with MS

Labels: